Abstract

AbstractThe monocyclo‐diendiyne → bicyclo‐trienediyne strategy for obtaining dienediyne models of the antitumor antibiotic neocarzinostatin chromophore (1) was extended from generating 6‐/11‐membered bicyclotrienediynes (e.g. 2 → 4) to generating the 6‐/10‐membered bicyclotrienediyne 5. In the preparatory steps (Scheme 2), the bistriflate 10 was successively coupled with alkynes 9 and 11. Via the dienediynediol and its subsequent oxidation with the Dess‐Martin periodinane, we obtained the monocyclic dienediyne keto aldehyde 13. Cyclization of 13 with low‐valent titanium afforded the bicyclotrienediyne 5 in 42% yield (Scheme 3). Compound 5 was converted in five steps – namely ketal cleavage, monosilylation of the resulting diol 14, asymmetric Sharpless epoxidation, desilylation and carbonate formation – into the dienediyne epoxycarbonate 3. The structure of the latter is more closely related to the neocarzinostatin chromophore than our earlier analogues.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.